GenomeWeb/Mizuho Survey Finds Researchers Optimistic for Sequencing Funding, Market Growth | GenomeWeb

The genomics research community is optimistic that sequencing will continue to see an increase in research funding over the next 12 months, according to a survey conducted by GenomeWeb in collaboration with Mizuho Securities.

The survey also found that respondents expect sequencing to overtake microarrays in most applications within five years, that they believe sequencing will penetrate the consumer market within approximately six years, and that the average price point at which most respondents would get their genome sequenced is $700.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.